Xoma reported $-4372000 in EBIT for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Agenus AGEN:US USD -41652000 3.32M
Agios Pharmaceuticals AGIO:US USD -91090000 6.55M
Biomarin Pharmaceutical BMRN:US USD 2.38M 36.77M
Bluebird Bio BLUE:US USD -86480000 14.28M
Chimerix CMRX:US USD 11.65M 35.09M
Eli Lilly And LLY:US USD 1.95B 294.9M
Intercept Pharmaceuticals ICPT:US USD -10144000 3.22M
Life Technologies LIFE:US USD -13492000 908K
Macrogenics MGNX:US USD -24955000 16.85M
Novartis NVS:US USD 3.33B 8M
Novartis NOVN:VX USD 3.33B 8M
Pfizer PFE:US USD 9.7B 2.43B
Regeneron Pharmaceuticals REGN:US USD 1.22B 83.2M
Teva Pharmaceutical Industries TEVA:US USD 740M 6M
Xoma XOMA:US USD -4372000 395K
YTE INCY:US USD 118.25M 142.04M